Home Biotechnology Autologous Cell Therapy Market

Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Cell Type (Hematopoietic Stem Cells (HSCs), Mesenchymal Stem Cells (MSCs), Chondrocytes, Fibroblasts, Keratinocytes, Other Autologous Cells), By Source (Epidermis, Bone Marrow, Mesenchymal Stem Cells, Haematopoietic Stem Cells, Chondrocytes, Others), By Application (Cancer, Cardiovascular Disorders, Neurodegenerative Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Others), By End-User (Hospitals & Clinics, Ambulatory Centers, Academics & Research, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Dhanashri B | Format: | Report Code: SRBI57346DR | Pages: 150

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Regulatory Framework
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  7. ESG Trends
  8. Global Autologous Cell Therapy Market Size Analysis
    1. Global Autologous Cell Therapy Market Introduction
    2. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. Hematopoietic Stem Cells (HSCs)
        1. By Value
      3. Mesenchymal Stem Cells (MSCs)
        1. By Value
      4. Chondrocytes
        1. By Value
      5. Fibroblasts
        1. By Value
      6. Keratinocytes
        1. By Value
      7. Other Autologous Cells
        1. By Value
    3. By Source
      1. Introduction
        1. Source By Value
      2. Epidermis
        1. By Value
      3. Bone Marrow
        1. By Value
      4. Mesenchymal Stem Cells
        1. By Value
      5. Haematopoietic Stem Cells
        1. By Value
      6. Chondrocytes
        1. By Value
      7. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurodegenerative Disorders
        1. By Value
      5. Autoimmune Disorders
        1. By Value
      6. Orthopedics
        1. By Value
      7. Wound Healing
        1. By Value
      8. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals & Clinics
        1. By Value
      3. Ambulatory Centers
        1. By Value
      4. Academics & Research
        1. By Value
      5. Others
        1. By Value
  9. North America Market Analysis
    1. Introduction
    2. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. Hematopoietic Stem Cells (HSCs)
        1. By Value
      3. Mesenchymal Stem Cells (MSCs)
        1. By Value
      4. Chondrocytes
        1. By Value
      5. Fibroblasts
        1. By Value
      6. Keratinocytes
        1. By Value
      7. Other Autologous Cells
        1. By Value
    3. By Source
      1. Introduction
        1. Source By Value
      2. Epidermis
        1. By Value
      3. Bone Marrow
        1. By Value
      4. Mesenchymal Stem Cells
        1. By Value
      5. Haematopoietic Stem Cells
        1. By Value
      6. Chondrocytes
        1. By Value
      7. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurodegenerative Disorders
        1. By Value
      5. Autoimmune Disorders
        1. By Value
      6. Orthopedics
        1. By Value
      7. Wound Healing
        1. By Value
      8. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals & Clinics
        1. By Value
      3. Ambulatory Centers
        1. By Value
      4. Academics & Research
        1. By Value
      5. Others
        1. By Value
    6. U.S.
      1. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. Hematopoietic Stem Cells (HSCs)
          1. By Value
        3. Mesenchymal Stem Cells (MSCs)
          1. By Value
        4. Chondrocytes
          1. By Value
        5. Fibroblasts
          1. By Value
        6. Keratinocytes
          1. By Value
        7. Other Autologous Cells
          1. By Value
      2. By Source
        1. Introduction
          1. Source By Value
        2. Epidermis
          1. By Value
        3. Bone Marrow
          1. By Value
        4. Mesenchymal Stem Cells
          1. By Value
        5. Haematopoietic Stem Cells
          1. By Value
        6. Chondrocytes
          1. By Value
        7. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurodegenerative Disorders
          1. By Value
        5. Autoimmune Disorders
          1. By Value
        6. Orthopedics
          1. By Value
        7. Wound Healing
          1. By Value
        8. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals & Clinics
          1. By Value
        3. Ambulatory Centers
          1. By Value
        4. Academics & Research
          1. By Value
        5. Others
          1. By Value
    7. Canada
  10. Europe Market Analysis
    1. Introduction
    2. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. Hematopoietic Stem Cells (HSCs)
        1. By Value
      3. Mesenchymal Stem Cells (MSCs)
        1. By Value
      4. Chondrocytes
        1. By Value
      5. Fibroblasts
        1. By Value
      6. Keratinocytes
        1. By Value
      7. Other Autologous Cells
        1. By Value
    3. By Source
      1. Introduction
        1. Source By Value
      2. Epidermis
        1. By Value
      3. Bone Marrow
        1. By Value
      4. Mesenchymal Stem Cells
        1. By Value
      5. Haematopoietic Stem Cells
        1. By Value
      6. Chondrocytes
        1. By Value
      7. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurodegenerative Disorders
        1. By Value
      5. Autoimmune Disorders
        1. By Value
      6. Orthopedics
        1. By Value
      7. Wound Healing
        1. By Value
      8. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals & Clinics
        1. By Value
      3. Ambulatory Centers
        1. By Value
      4. Academics & Research
        1. By Value
      5. Others
        1. By Value
    6. U.K.
      1. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. Hematopoietic Stem Cells (HSCs)
          1. By Value
        3. Mesenchymal Stem Cells (MSCs)
          1. By Value
        4. Chondrocytes
          1. By Value
        5. Fibroblasts
          1. By Value
        6. Keratinocytes
          1. By Value
        7. Other Autologous Cells
          1. By Value
      2. By Source
        1. Introduction
          1. Source By Value
        2. Epidermis
          1. By Value
        3. Bone Marrow
          1. By Value
        4. Mesenchymal Stem Cells
          1. By Value
        5. Haematopoietic Stem Cells
          1. By Value
        6. Chondrocytes
          1. By Value
        7. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurodegenerative Disorders
          1. By Value
        5. Autoimmune Disorders
          1. By Value
        6. Orthopedics
          1. By Value
        7. Wound Healing
          1. By Value
        8. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals & Clinics
          1. By Value
        3. Ambulatory Centers
          1. By Value
        4. Academics & Research
          1. By Value
        5. Others
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
  11. APAC Market Analysis
    1. Introduction
    2. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. Hematopoietic Stem Cells (HSCs)
        1. By Value
      3. Mesenchymal Stem Cells (MSCs)
        1. By Value
      4. Chondrocytes
        1. By Value
      5. Fibroblasts
        1. By Value
      6. Keratinocytes
        1. By Value
      7. Other Autologous Cells
        1. By Value
    3. By Source
      1. Introduction
        1. Source By Value
      2. Epidermis
        1. By Value
      3. Bone Marrow
        1. By Value
      4. Mesenchymal Stem Cells
        1. By Value
      5. Haematopoietic Stem Cells
        1. By Value
      6. Chondrocytes
        1. By Value
      7. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurodegenerative Disorders
        1. By Value
      5. Autoimmune Disorders
        1. By Value
      6. Orthopedics
        1. By Value
      7. Wound Healing
        1. By Value
      8. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals & Clinics
        1. By Value
      3. Ambulatory Centers
        1. By Value
      4. Academics & Research
        1. By Value
      5. Others
        1. By Value
    6. China
      1. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. Hematopoietic Stem Cells (HSCs)
          1. By Value
        3. Mesenchymal Stem Cells (MSCs)
          1. By Value
        4. Chondrocytes
          1. By Value
        5. Fibroblasts
          1. By Value
        6. Keratinocytes
          1. By Value
        7. Other Autologous Cells
          1. By Value
      2. By Source
        1. Introduction
          1. Source By Value
        2. Epidermis
          1. By Value
        3. Bone Marrow
          1. By Value
        4. Mesenchymal Stem Cells
          1. By Value
        5. Haematopoietic Stem Cells
          1. By Value
        6. Chondrocytes
          1. By Value
        7. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurodegenerative Disorders
          1. By Value
        5. Autoimmune Disorders
          1. By Value
        6. Orthopedics
          1. By Value
        7. Wound Healing
          1. By Value
        8. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals & Clinics
          1. By Value
        3. Ambulatory Centers
          1. By Value
        4. Academics & Research
          1. By Value
        5. Others
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
  12. Middle East and Africa Market Analysis
    1. Introduction
    2. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. Hematopoietic Stem Cells (HSCs)
        1. By Value
      3. Mesenchymal Stem Cells (MSCs)
        1. By Value
      4. Chondrocytes
        1. By Value
      5. Fibroblasts
        1. By Value
      6. Keratinocytes
        1. By Value
      7. Other Autologous Cells
        1. By Value
    3. By Source
      1. Introduction
        1. Source By Value
      2. Epidermis
        1. By Value
      3. Bone Marrow
        1. By Value
      4. Mesenchymal Stem Cells
        1. By Value
      5. Haematopoietic Stem Cells
        1. By Value
      6. Chondrocytes
        1. By Value
      7. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurodegenerative Disorders
        1. By Value
      5. Autoimmune Disorders
        1. By Value
      6. Orthopedics
        1. By Value
      7. Wound Healing
        1. By Value
      8. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals & Clinics
        1. By Value
      3. Ambulatory Centers
        1. By Value
      4. Academics & Research
        1. By Value
      5. Others
        1. By Value
    6. UAE
      1. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. Hematopoietic Stem Cells (HSCs)
          1. By Value
        3. Mesenchymal Stem Cells (MSCs)
          1. By Value
        4. Chondrocytes
          1. By Value
        5. Fibroblasts
          1. By Value
        6. Keratinocytes
          1. By Value
        7. Other Autologous Cells
          1. By Value
      2. By Source
        1. Introduction
          1. Source By Value
        2. Epidermis
          1. By Value
        3. Bone Marrow
          1. By Value
        4. Mesenchymal Stem Cells
          1. By Value
        5. Haematopoietic Stem Cells
          1. By Value
        6. Chondrocytes
          1. By Value
        7. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurodegenerative Disorders
          1. By Value
        5. Autoimmune Disorders
          1. By Value
        6. Orthopedics
          1. By Value
        7. Wound Healing
          1. By Value
        8. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals & Clinics
          1. By Value
        3. Ambulatory Centers
          1. By Value
        4. Academics & Research
          1. By Value
        5. Others
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
  13. LATAM Market Analysis
    1. Introduction
    2. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. Hematopoietic Stem Cells (HSCs)
        1. By Value
      3. Mesenchymal Stem Cells (MSCs)
        1. By Value
      4. Chondrocytes
        1. By Value
      5. Fibroblasts
        1. By Value
      6. Keratinocytes
        1. By Value
      7. Other Autologous Cells
        1. By Value
    3. By Source
      1. Introduction
        1. Source By Value
      2. Epidermis
        1. By Value
      3. Bone Marrow
        1. By Value
      4. Mesenchymal Stem Cells
        1. By Value
      5. Haematopoietic Stem Cells
        1. By Value
      6. Chondrocytes
        1. By Value
      7. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurodegenerative Disorders
        1. By Value
      5. Autoimmune Disorders
        1. By Value
      6. Orthopedics
        1. By Value
      7. Wound Healing
        1. By Value
      8. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals & Clinics
        1. By Value
      3. Ambulatory Centers
        1. By Value
      4. Academics & Research
        1. By Value
      5. Others
        1. By Value
    6. Brazil
      1. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. Hematopoietic Stem Cells (HSCs)
          1. By Value
        3. Mesenchymal Stem Cells (MSCs)
          1. By Value
        4. Chondrocytes
          1. By Value
        5. Fibroblasts
          1. By Value
        6. Keratinocytes
          1. By Value
        7. Other Autologous Cells
          1. By Value
      2. By Source
        1. Introduction
          1. Source By Value
        2. Epidermis
          1. By Value
        3. Bone Marrow
          1. By Value
        4. Mesenchymal Stem Cells
          1. By Value
        5. Haematopoietic Stem Cells
          1. By Value
        6. Chondrocytes
          1. By Value
        7. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurodegenerative Disorders
          1. By Value
        5. Autoimmune Disorders
          1. By Value
        6. Orthopedics
          1. By Value
        7. Wound Healing
          1. By Value
        8. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals & Clinics
          1. By Value
        3. Ambulatory Centers
          1. By Value
        4. Academics & Research
          1. By Value
        5. Others
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
  14. Competitive Landscape
    1. Autologous Cell Therapy Market Share By Players
    2. M&A Agreements & Collaboration Analysis
  15. Market Players Assessment
    1. Vericel Corporation
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. BrainStorm Cell Therapeutics Inc.
    3. Holostem Terapie Avanzate S.r.l.
    4. Takeda Pharmaceutical Company Limited
    5. DON AG
    6. BioTime, Inc. (now Lineage Cell Therapeutics)
    7. Castle Creek Biosciences, Inc.
    8. Iovance Biotherapeutics, Inc.
    9. Regeneus Ltd
    10. Celgene Corporation (a Bristol-Myers Squibb company)
    11. Novartis AG
    12. Pharmicell Co., Ltd.
    13. Medipost Co., Ltd.
  16. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  17. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  18. Disclaimer
Get This Report

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.